Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 88851-88900 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04939207
Safety and Cost-efficiëncy of New Imaging Techniques in Patients Suspected of Coronary Artery Disease
NARecruiting
825 participants
Started: Mar 22, 2022 · Completed: Apr 1, 2025
1 condition3 sponsors4 locations
NCT05426252
Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
PHASE1/PHASE2Recruiting
20 participants
Started: Mar 22, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06320496
Evaluation of the Effect of a Physical Activity Recovery Stay
N/ARecruiting
50 participants
Started: Mar 22, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05180591
Repeat BCG Vaccinations for the Treatment of Pediatric Type 1 Diabetes
PHASE2Recruiting
150 participants
Started: Mar 22, 2022 · Completed: Mar 31, 2027
3 conditions1 sponsor1 location
NCT04655365
Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.
PHASE2Active, not recruiting
50 participants
Started: Mar 22, 2022 · Completed: Sep 1, 2026
1 condition2 sponsors4 locations
NCT05091788
Robotic Mechanical Coring for the Treatment of Moderate to Severe Facial Wrinkles
NARecruiting
70 participants
Started: Mar 22, 2022 · Completed: Aug 15, 2025
1 condition1 sponsor2 locations
NCT05303922
Dual-Energy Computed Tomography (DECT) in Acute Neck Infections: Comparison With Magnetic Resonance Imaging (MRI)
NARecruiting
50 participants
Started: Mar 22, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05189262
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
N/ARecruiting
150 participants
Started: Mar 22, 2022 · Completed: Dec 1, 2027
3 conditions2 sponsors1 location
NCT05241444
CD4^LVFOXP3 in Participants With IPEX
PHASE1Recruiting
30 participants
Started: Mar 22, 2022 · Completed: Feb 28, 2037
1 condition2 sponsors1 location
NCT06207864
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
NARecruiting
1,001 participants
Started: Mar 22, 2022 · Completed: Dec 31, 2030
1 condition2 sponsors1 location
NCT05264545
Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients
NAActive, not recruiting
100 participants
Started: Mar 22, 2022 · Completed: Oct 31, 2026
1 condition2 sponsors8 locations
NCT05236465
A 3-day Course for CFS/ME
NARecruiting
100 participants
Started: Mar 21, 2022 · Completed: Dec 1, 2026
2 conditions5 sponsors1 location
NCT05264896
Perioperative FLOT vs Adjuvant XELOX for CA Stomach
PHASE3Recruiting
110 participants
Started: Mar 21, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05297136
Preoperative Endoscopic Pancreatic Stent for Distal Pancreatectomy
NARecruiting
56 participants
Started: Mar 21, 2022 · Completed: May 20, 2026
2 conditions1 sponsor1 location
NCT05382663
The Jordan Study for End-Stage Renal Disease Subjects
NARecruiting
75 participants
Started: Mar 21, 2022 · Completed: Nov 1, 2024
1 condition1 sponsor1 location
NCT05126147
Hydroxychloroquine in Mild Graves' Orbitopathy
PHASE4Recruiting
108 participants
Started: Mar 21, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT05202782
Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma
PHASE2Active, not recruiting
24 participants
Started: Mar 21, 2022 · Completed: Oct 9, 2029
19 conditions2 sponsors2 locations
NCT05015426
Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT
PHASE1Active, not recruiting
20 participants
Started: Mar 21, 2022 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT05249959
Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients.
PHASE2Recruiting
49 participants
Started: Mar 21, 2022 · Completed: Mar 31, 2029
2 conditions1 sponsor21 locations
NCT04137133
Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine
NARecruiting
20 participants
Started: Mar 21, 2022 · Completed: Mar 31, 2030
1 condition1 sponsor1 location
NCT05562518
GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.
PHASE4Recruiting
160 participants
Started: Mar 21, 2022 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT05781763
High-intensity Training in Patients With Spondyloarthritis: a Randomized Controlled Trial
NARecruiting
100 participants
Started: Mar 21, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05387369
A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19
N/ARecruiting
2,000 participants
Started: Mar 21, 2022 · Completed: Mar 30, 2027
1 condition1 sponsor1 location
NCT04973423
STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP
NARecruiting
180 participants
Started: Mar 21, 2022 · Completed: Aug 21, 2027
3 conditions1 sponsor17 locations
NCT04994249
Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation
N/ARecruiting
250 participants
Started: Mar 21, 2022 · Completed: Dec 31, 2027
4 conditions2 sponsors1 location
NCT04754165
Postoperative VR for Recovery After Bariatric Surgery
NAActive, not recruiting
106 participants
Started: Mar 21, 2022 · Completed: Jun 30, 2026
3 conditions3 sponsors1 location
NCT05233605
Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation
N/ARecruiting
72 participants
Started: Mar 21, 2022 · Completed: Feb 4, 2026
1 condition1 sponsor1 location
NCT04920149
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
PHASE2Recruiting
150 participants
Started: Mar 21, 2022 · Completed: Sep 30, 2045
3 conditions3 sponsors8 locations
NCT05354973
ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy
N/ARecruiting
11 participants
Started: Mar 21, 2022 · Completed: Apr 30, 2025
2 conditions3 sponsors1 location
NCT05333666
The Association Between Non-vitamin K Antagonist Oral Anticoagulant Concentration and Clinical Outcomes.
N/ARecruiting
1,500 participants
Started: Mar 21, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT06007560
Aerobe Cycling Training in Women With Unexplained Recurrent Pregnancy Loss
NAActive, not recruiting
30 participants
Started: Mar 21, 2022 · Completed: Jun 1, 2026
1 condition2 sponsors2 locations
NCT05133427
HIFU for Treatment of Non-nodular and Recurrent BCC
NAActive, not recruiting
40 participants
Started: Mar 21, 2022 · Completed: Dec 1, 2026
1 condition2 sponsors2 locations
NCT05365048
Provider Recommendation and HPV Vaccination
NARecruiting
301,201 participants
Started: Mar 21, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05077800
FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer
PHASE2Active, not recruiting
70 participants
Started: Mar 21, 2022 · Completed: Jul 31, 2026
2 conditions3 sponsors3 locations
NCT05235061
HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) -Post-Traumatic Epilepsy (PTE)
NAActive, not recruiting
160 participants
Started: Mar 21, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05020496
Trem-1 and Ultraviolet Radiation-induced Immune Suppression
EARLY_PHASE1Active, not recruiting
70 participants
Started: Mar 21, 2022 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT05206942
Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy
NARecruiting
30 participants
Started: Mar 21, 2022 · Completed: Feb 28, 2026
1 condition3 sponsors1 location
NCT05620264
Validation of Interleukins and Other Cytokines Together With OCT Imaging for Rapid Infectious Keratitis Assessment
N/ARecruiting
392 participants
Started: Mar 21, 2022 · Completed: Oct 15, 2024
2 conditions1 sponsor1 location
NCT05398094
Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
PHASE2Recruiting
19 participants
Started: Mar 21, 2022 · Completed: Dec 31, 2028
2 conditions1 sponsor20 locations
NCT04644211
Ruxolitinib in Thrombocythemia and Polycythemia Vera
PHASE2Recruiting
60 participants
Started: Mar 21, 2022 · Completed: Jul 31, 2034
2 conditions2 sponsors4 locations
NCT05420259
Combined Exercise and Nutritional Intervention in GI Cancer Patients
NARecruiting
68 participants
Started: Mar 21, 2022 · Completed: Jun 28, 2024
4 conditions1 sponsor2 locations
NCT06183060
Study on the Decision Support System of Difficult Airway Evaluation
N/ARecruiting
1,000 participants
Started: Mar 21, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05151484
Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover
PHASE4Recruiting
60 participants
Started: Mar 21, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT06723704
Prognosis in Adult Patients with Congenital Heart Disease
N/ARecruiting
450 participants
Started: Mar 21, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05034692
Application of Overlap Method to Digestive Tract Reconstruction of Totally Laparoscopic Left Colectomy
NARecruiting
60 participants
Started: Mar 21, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05240716
Functional Electrical Stimulation on Tibial Nerve in Stroke Patients.
NARecruiting
15 participants
Started: Mar 21, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04526600
Fidgeting and Attentional and Emotional Regulation in ADHD
NARecruiting
109 participants
Started: Mar 21, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05299970
Fermented Millet Porridge, Gut Microbiota and Inflammation Status in Women
NARecruiting
80 participants
Started: Mar 21, 2022 · Completed: Jul 31, 2024
2 conditions3 sponsors1 location
NCT04869917
Behavioral Nudges for Diabetes Prevention (BEGIN) Trial in Primary Care
NAActive, not recruiting
960 participants
Started: Mar 21, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06977217
Factors Associated With Response to Cardiac Resynchronization Therapy in Heart Failure Patients With Non-LBBB ECG Pattern
N/AActive, not recruiting
270 participants
Started: Mar 21, 2022 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location